Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril
- 1 April 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 49 (6) , 1550-1551
- https://doi.org/10.1016/0002-9149(82)90386-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.Published by Wiley ,1981
- Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin IClinical Pharmacology & Therapeutics, 1981
- Clinical use of an orally acting converting enzyme inhibitor: captopril.Hypertension, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRILThe Lancet, 1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978